Saori Furuta (IMAGE)

DOE/Lawrence Berkeley National Laboratory

Saori Furuta

Caption

Saori Furuta, Berkeley Lab’s Life Sciences Division was part of a study that linked the FAM83A protein to the resistance of breast cancer to the therapeutic drugs known as EGFR-TKIs.

Credit

Robert Lee Del Chiaro

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.